Henrik Zetterberg on Cochrane Asks for Field’s Input on Draft Reporting Standards

COMMENT When looking in PubMed, one sees that there is an exponential increase in the number of studies on biomarkers for AD, and the opportunities should be excellent for making meta-analyses on the topic. However, if one sets out to curate the literature, it wi

Jana Podhorna

Medicine
Germany

Cochrane Asks for Field’s Input on Draft Reporting Standards

CONFERENCE COVERAGE 2012-08-03 Conference Coverage Most researchers agree that clinical dementia papers need reporting standards, especially when it comes to diagnostic tests. Say you are interested in this question: How well does a given biomarker predict Alzheimer’s disease (AD), or

Weeding Mendel’s Garden: Can We Hoe Dubious Genetic Associations?

WEBINAR 2012-08-03 Scientists have uncovered hundreds of genetic variants that purportedly cause familial forms of various neurodegenerative diseases, including Alzheimer’s, Parkinson’s, frontotemporal dementias, and amyotrophic lateral sclerosis. But are all of these assoc

PAPER Mandemakers W, Snellinx A, O'Neill MJ, de Strooper B

LRRK2 expression is enriched in the striosomal compartment of mouse striatum.

Neurobiol Dis. 2012 Dec;48(3):582-93. Epub 2012 Jul 29 PubMed: 22850484

PAPER Otomo A, Pan L, Hadano S

Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases.

Neurol Res Int. 2012;2012:498428. PubMed: 22852081

PAPER Chacón PJ, Rodríguez-Tébar A

Increased expression of the homologue of enhancer-of-split 1 protects neurons from beta amyloid neurotoxicity and hints at an alternative role for transforming growth factor beta1 as a neuroprotector.

Alzheimers Res Ther. 2012 Jul 31;4(4):31. PubMed: 22849569

PAPER Morgan CD, Murphy C

Individuals at risk for Alzheimer's disease show differential patterns of ERP brain activation during odor identification.

Behav Brain Funct. 2012 Jul 31;8(1):37. PubMed: 22849610

PAPER Dhikav V, Anand KS

Are vascular factors linked to the development of hippocampal atrophy in Alzheimer's disease?

J Alzheimers Dis. 2012 Jan 1;32(3):711-8. PubMed: 22850312

PAPER Bell RD

The imbalance of vascular molecules in Alzheimer's disease.

J Alzheimers Dis. 2012 Jan 1;32(3):699-709. PubMed: 22850315

PAPER Ambrose CT

Neuroangiogenesis: a vascular basis for Alzheimer's disease and cognitive decline during aging.

J Alzheimers Dis. 2012 Jan 1;32(3):773-88. PubMed: 22850316

PAPER

Upcoming meetings related to Alzheimer's disease.

Eur J Neurol. 2006 Dec;13(12):1374-7. PubMed: 22850343

PAPER Steele JW, Lachenmayer ML, Ju S, Stock A, Liken J, Kim SH, Delgado LM, Alfaro IE, Bernales S, Verdile G, Bharadwaj P, Gupta V, Barr R, Friss A, Dolios G, Wang R, Ringe D, Fraser P, Westaway D, St George-Hyslop PH, Szabo P, Relkin NR, Buxbaum JD, Glabe CG, Protter AA, Martins RN, Ehrlich ME, Petsko GA, Yue Z, Gandy S

Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model.

Mol Psychiatry. 2012 Jul 31; PubMed: 22850627

PAPER Giunta B, Obregon D, Velisetty R, Sanberg PR, Borlongan CV, Tan J

The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention.

J Neuroinflammation. 2012;9:185. PubMed: 22849382

PAPER Böttner M, Zorenkov D, Hellwig I, Barrenschee M, Harde J, Fricke T, Deuschl G, Egberts JH, Becker T, Fritscher-Ravens A, Arlt A, Wedel T

Expression pattern and localization of alpha-synuclein in the human enteric nervous system.

Neurobiol Dis. 2012 Dec;48(3):474-80. PubMed: 22850485